Abstract
Adeno-associated virus (AAV) vector system has several useful advantages with regard to in vitro and in vivo gene transfer. However, their usages have been limited by cumbersome and labor-intensive vector production in the traditional method. To overcome limitations in AAV production, in this report, we explored the possibility of generating AAV packaging cell line, 293T R/C.VA.E2A.E4. cells, by using lentivirus-mediated transduction of Rep/Cap gene of AAV-2, VA RNA, E2A, and E4 genes of Ad5 into 293T cells. In packaging cell lines, it is important that supply of the AAV vector can be stably performed for long time. We showed that the 293T R/C.VA.E2A.E4. cells have stably maintained the transduced components after more than 10 passages and yielded high-titer AAV vectors, and the titer of AAV vectors did not decline even if culture of the packaging cells was continued for long time. The Rep/Cap and E4 gene products caused no remarkable cytotoxicity. The 293T R/C.VA.E2A.E4. cells might be able to tolerate the Rep/Cap and E4 gene products, or have less copy numbers of the Rep/Cap and E4 genes than the traditional method. Moreover, we showed that the AAV vectors derived from 293T R/C.VA.E2A.E4. cells infected the primary human CD34...Continue Reading
References
Oct 1, 1992·Journal of Virology·Q YangJ P Trempe
Apr 1, 1991·Virology·S N KhleifJ P Trempe
Sep 1, 1989·Journal of Virology·R J SamulskiT Shenk
Jun 1, 1989·Journal of Virology·M M Huang, P Hearing
Oct 1, 1988·Virology·E MendelsonB J Carter
Nov 1, 1986·Journal of Virology·K Voelkerding, D F Klessig
Oct 1, 1987·Journal of Virology·R J SamulskiT Shenk
Dec 15, 1982·Journal of Molecular Biology·P SarnowA J Levine
Oct 1, 1994·Molecular Biotechnology·D S Latchman
Jul 1, 1994·Human Gene Therapy·R M Kotin
Nov 27, 1995·Annals of the New York Academy of Sciences·K I Berns, C Giraud
Oct 1, 1995·Human Gene Therapy·K R ClarkP R Johnson
May 1, 1996·Journal of Virology·F K FerrariR J Samulski
Dec 1, 1995·Human Gene Therapy·J A ChioriniR M Kotin
Nov 1, 1996·Journal of Virology·X XiaoR J Samulski
Mar 1, 1997·Journal of Virology·K A VincentS C Wadsworth
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·M NevelsT Dobner
Jan 1, 1997·Gene Therapy·A L PeelP J Reier
May 1, 1997·Journal of Virology·J G Teodoro, P E Branton
Sep 1, 1997·Journal of Virology·U BlömerF H Gage
Mar 14, 1998·Journal of Virology·X XiaoR J Samulski
Apr 29, 1998·Human Gene Therapy·A SalvettiP Moullier
Aug 8, 1998·Journal of Virology·N Inoue, D W Russell
Oct 10, 1998·Journal of Virology·T DullL Naldini
Dec 16, 1998·Journal of Virology·D DuanJ F Engelhardt
May 1, 1999·Human Gene Therapy·K R ClarkP R Johnson
Aug 10, 1999·Journal of Virology·F D Goodrum, D A Ornelles
Nov 30, 1999·Molecular Cell Biology Research Communications : MCBRC·K W Adolph, P Bornstein
Dec 10, 1999·Journal of Virology·S WienzekM Dobbelstein
Dec 30, 1999·Nature Genetics·F ParkM A Kay
Sep 22, 2000·Virology·H Zhou, A L Beaudet